Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Schuler

Showing results (201-210 of 298) with videos related to

Pageof 30
Sort By:
Oncotarget|May 17, 2017
Molecular dissection of effector mechanisms of RAS-mediated resistance to anti-EGFR antibody therapyStefan Kasper, Henning Reis, Sophie Ziegler, et al.
EMBO Molecular Medicine|April 25, 2025
Alpha-synuclein misfolding as fluid biomarker for Parkinson's disease measured with the iRS platformMartin Schuler, Grischa Gerwert, Marvin Mann, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 17, 2012
Folylpoly-glutamate synthetase expression is associated with tumor response and outcome from pemetrexed-based chemotherapy in malignant pleural mesotheliomaDaniel C Christoph, Bernadette Reyna Asuncion, Celine Mascaux, et al.
EJNMMI Research|March 13, 2026
Comparison between [<sup>68</sup>Ga]Ga-FAPI-46 and [<sup>18</sup>F]FDG PET/CT uptake in luminal-like vs. HER2-positive breast cancerAlina Toni Küper, Sofia Carrilho Vaz, Kim Magaly Pabst, et al.
The Oncologist|March 31, 2026
MyCODE: A prospective evaluation of Lay-language Molecular Tumor Board Protocols in Precision OncologyIna Pretzell, Anke Fleischhauer, Ilektra Mavroeidi, et al.
Nature Medicine|August 12, 2022
Pan-cancer efficacy of pralsetinib in patients with RET fusion-positive solid tumors from the phase 1/2 ARROW trialVivek Subbiah, Philippe A Cassier, Salvatore Siena, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 8, 2026
Prognostic Value of Fibroblast Activation Protein-Directed PET Imaging in Pleural MesotheliomaLukas Kessler, Felix Schwaning, Martin Metzenmacher, et al.
Breast Cancer Research and Treatment|March 31, 2010
Ep-CAM RNA expression predicts metastasis-free survival in three cohorts of untreated node-negative breast cancerMarcus Schmidt, Ilka Brigitte Petry, Daniel Böhm, et al.
JCO Precision Oncology|September 11, 2020
Efficacy of Vemurafenib in Patients With Non-Small-Cell Lung Cancer With <i>BRAF</i> V600 Mutation: An Open-Label, Single-Arm Cohort of the Histology-Independent VE-BASKET StudyVivek Subbiah, Radj Gervais, Gregory Riely, et al.
Cancers|February 9, 2020
Plasma Next Generation Sequencing and Droplet Digital-qPCR-Based Quantification of Circulating Cell-Free RNA for Noninvasive Early Detection of CancerMartin Metzenmacher, Renáta Váraljai, Balazs Hegedüs, et al.
Pageof 30

Showing results (201-210 of 298) with videos related to

Sort By:
Pageof 30
Oncotarget|May 17, 2017
Molecular dissection of effector mechanisms of RAS-mediated resistance to anti-EGFR antibody therapyStefan Kasper, Henning Reis, Sophie Ziegler, et al.
EMBO Molecular Medicine|April 25, 2025
Alpha-synuclein misfolding as fluid biomarker for Parkinson's disease measured with the iRS platformMartin Schuler, Grischa Gerwert, Marvin Mann, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 17, 2012
Folylpoly-glutamate synthetase expression is associated with tumor response and outcome from pemetrexed-based chemotherapy in malignant pleural mesotheliomaDaniel C Christoph, Bernadette Reyna Asuncion, Celine Mascaux, et al.
EJNMMI Research|March 13, 2026
Comparison between [<sup>68</sup>Ga]Ga-FAPI-46 and [<sup>18</sup>F]FDG PET/CT uptake in luminal-like vs. HER2-positive breast cancerAlina Toni Küper, Sofia Carrilho Vaz, Kim Magaly Pabst, et al.
The Oncologist|March 31, 2026
MyCODE: A prospective evaluation of Lay-language Molecular Tumor Board Protocols in Precision OncologyIna Pretzell, Anke Fleischhauer, Ilektra Mavroeidi, et al.
Nature Medicine|August 12, 2022
Pan-cancer efficacy of pralsetinib in patients with RET fusion-positive solid tumors from the phase 1/2 ARROW trialVivek Subbiah, Philippe A Cassier, Salvatore Siena, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 8, 2026
Prognostic Value of Fibroblast Activation Protein-Directed PET Imaging in Pleural MesotheliomaLukas Kessler, Felix Schwaning, Martin Metzenmacher, et al.
Breast Cancer Research and Treatment|March 31, 2010
Ep-CAM RNA expression predicts metastasis-free survival in three cohorts of untreated node-negative breast cancerMarcus Schmidt, Ilka Brigitte Petry, Daniel Böhm, et al.
JCO Precision Oncology|September 11, 2020
Efficacy of Vemurafenib in Patients With Non-Small-Cell Lung Cancer With <i>BRAF</i> V600 Mutation: An Open-Label, Single-Arm Cohort of the Histology-Independent VE-BASKET StudyVivek Subbiah, Radj Gervais, Gregory Riely, et al.
Cancers|February 9, 2020
Plasma Next Generation Sequencing and Droplet Digital-qPCR-Based Quantification of Circulating Cell-Free RNA for Noninvasive Early Detection of CancerMartin Metzenmacher, Renáta Váraljai, Balazs Hegedüs, et al.
Pageof 30